GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
GSK’s Trelegy, a treatment for chronic obstructive pulmonary disease (COPD), aimed to address a gap in the market with its ...
The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.
Grillo’s wants to be a lifestyle brand as much as a pickle company. And, well, it’s working. If you’re an upstart pickle ...
GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...
GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.
For many people, whitening toothpaste is the easiest and most affordable tool to turn to if you're trying to brighten up your smile. While a solid toothpaste marketed for its teeth-whitening ...
WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...
Teva Pharmaceutical Industries Ltd. ADR 1.52% $19.75B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback